C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13148870

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the treatment of cancer. More specifically, the present invention relates to the use of c-cbl as a marker for the diagnosis and/or prognosis of cancer, and to the use of a c-cbl antagonist for the treatment of a cancer associated with resistance to apoptosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C N R S)3 RUE MICHEL ANGE 75016 PARIS
UNIVERSITE CLAUDE BERNARD LYON 143 BOULEVARD DU 11 NOVEMBRE 1918 VILLEURBANNE 69100
CENTRE LEON-BERARD28 RUE LAENNEC LYON 69008

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Manie, Serge Thie, FR 2 2
Regnier, Daniel Vienne, FR 2 2
Tabone, Eric St Cyr Sur Le Rhone, FR 2 2
Yakoub, Sadok Saint Priest, FR 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation